In the United States, community-acquired pneumonia (CAP) is estimated to be responsible for 1.2 million emergency department visits and 41,210 deaths annually. This review summarizes the epidemiology, pathophysiology, microbiology, diagnosis, microbiologic testing, pharmacotherapy, and long-term adverse health outcomes for CAP in adults.
